Jacobs Levy Equity Management, Inc Acorda Therapeutics Inc Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.79 $454,238 - $647,560	-135,190 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.23 $411,258 - $595,812	-113,922 Reduced 45.73%	135,190 $645,000
Q1 2021 May 17, 2021	BUY	$3.8 - $8.04 $946,625 - $2 Million	249,112 New	249,112 $1.21 Million

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.